Multimodal oncology foundation model with Tempus and Pathos
Research partnerships Announcement
Disclosed: Verified: Partners: Tempus, Pathos
AstraZeneca agreed with Tempus and Pathos to build a large multimodal oncology foundation model from clinical and molecular data to support its cancer R&D.